The Therapeutic Potential of Metformin in Gastric Cancer

Gastric Cancer - Germany
doi 10.1007/s10120-019-00952-w
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

cMET as a Potential Therapeutic Target in Gastric Cancer (Review)

International Journal of Molecular Medicine
MedicineGenetics
2013English

COL12A1, a Novel Potential Prognostic Factor and Therapeutic Target in Gastric Cancer

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2019English

Rac1 Is Correlated With Aggressiveness and a Potential Therapeutic Target for Gastric Cancer

International Journal of Oncology
Cancer ResearchOncology
2015English

Systematic Approach Identifies RHOA as a Potential Biomarker Therapeutic Target for Asian Gastric Cancer

Oncotarget
Oncology
2016English

The Antidiabetic Drug Metformin Inhibits Gastric Cancer Cell Proliferation in Vitro and in Vivo

Molecular Cancer Therapeutics
Cancer ResearchOncology
2012English

A Mutational Signature in Gastric Cancer Suggests Therapeutic Strategies

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2015English

Differentially Expressed lncRNAs in Gastric Cancer Patients: A Potential Biomarker for Gastric Cancer Prognosis

Journal of Cancer
Oncology
2017English

The Role and Diagnostic Potential of Gastrokine 1 in Gastric Cancer

Cancer Management and Research
Oncology
2019English

Targeting ALK in Cancer: Therapeutic Potential of Proapoptotic Peptides

Cancers
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy